“Clinical and Peripheral Blood Markers Predict Relapsed Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant”. Graduate Medical Scholars Journal, vol. 1, no. S1, Dec. 2025, https://doi.org/10.1349/3143-6587.1.S1.14.